Chronic hepatitis C in saudi arabia: three years local experience in a university hospital.

Abstract:

BACKGROUND:Chronic hepatitis C (CHC) is a global infection. In Saudi Arabia, the prevalence of CHC is declining due to the implementation of a blood screening program. However, CHC still remains a leading cause of liver cirrhosis and hepatocellular carcinoma. OBJECTIVES:This is a retrospective study of CHC patients at the King Abdul Aziz University Hospital, Jeddah, Saudi Arabia. PATIENTS AND METHODS:Out of a total of 291 CHC patients from the hepatology clinic at King Abdul Aziz University hospital, Jeddah, 279 patients were included in the present study. They were primarily male (152, 54.5%), with a mean age of 50.41 ± 1.72 years. The majority of patients were either Saudi (108, 38.7%) or Egyptian (60, 21.5%). A total of 61 patients received combination treatment with pegylated interferon and ribavirin, and one patient with sickle-cell anemia received pegylated INF monotherapy. Demographic, clinical and laboratory features of the CHC patients, and their responses to treatment were studied. RESULTS:Decompensated cirrhosis was documented in 60 patients (21.5%), and hepatocellular carcinoma in 14 (5%). The mean level of serum alanine aminotransferase was 83.6 ± 231 u/L. The predominant genotype among the 70 patients tested, was genotype 4, followed by genotype 1 (39 and 18 patients, respectively). The sustained viral response (SVR) rate was 82.99%. The main predictive factors for SVR were baseline HCV viral load and rapid virologic response (RVR). The mean duration of follow-up was 4.2 ± .85 years. There were 24 patients who had liver disease-related mortality. CONCLUSIONS:our data showed that 22% of CHC patients progress to cirrhosis and another 22% had treatment. Liver related mortality was more common in patients with advanced cirrhosis.

journal_name

Hepat Mon

journal_title

Hepatitis monthly

authors

Akbar HO,Al Ghamdi A,Qattan F,Fallatah HI,Al Rumani M

doi

10.5812/hepatmon.6178

subject

Has Abstract

pub_date

2012-09-01 00:00:00

pages

e6178

issue

9

eissn

1735-143X

issn

1735-3408

journal_volume

12

pub_type

杂志文章
  • Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran.

    abstract:BACKGROUND:Infection with the hepatitis B virus (HBV) is an important global health problem. Knowledge of the geographic distribution pattern of HBV infection can help to control the spread of the disease. OBJECTIVES:To determine the prevalence of HBV infections and risk factors for the disease for the first time in B...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.36452

    authors: Ziaee M,Ebrahimzadeh A,Azarkar Z,Namaei MH,Saburi A,Fereidouni M,Bijari B,Karamian M,Sharifzadeh G

    更新日期:2016-08-14 00:00:00

  • Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C.

    abstract:BACKGROUND:Nearly 0.5% of Iranians are infected with HCV. Peginterferon-alpha-2a and Peginterferon-alpha-2b are the two available types of interferon for the treatment of hepatitis C. Comparing the results of these two treatments is still a challenge. OBJECTIVES:The aim of this study was to compare the results of Pegi...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.30780

    authors: Pouresmaeeli M,Alavian SM,Keshvari M,Salimi S,Mehrnoush L

    更新日期:2015-09-29 00:00:00

  • Impact of the IL-10 Promoter Gene Polymorphisms in the Severity of Chronic Hepatitis B Infection.

    abstract:BACKGROUND:Interleukin-10 (IL-10) is an important anti-inflammatory cytokine. The polymorphisms of its promoter gene have been considered to be related with the chronicity of hepatitis B infection. OBJECTIVES:The aim of this study was to evaluate the polymorphisms at different positions in the IL-10 promoter gene in p...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.28287v2

    authors: Ghaleh Baghi S,Alavian SM,Mehrnoush L,Salimi S

    更新日期:2015-07-22 00:00:00

  • Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review.

    abstract:CONTEXT:We briefly reviewed the evidence on the association of hepatitis C (HCV) infection with several aspects of mental and psychosocial health. EVIDENCE ACQUISITION:Medline was searched with appropriate keywords. The primary sources were the systematic reviews. If systematic reviews were not available for a subject...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.8340

    authors: Modabbernia A,Poustchi H,Malekzadeh R

    更新日期:2013-01-01 00:00:00

  • Epidemiology of hepatitis B in the reproductive-age female farmworkers of southeastern Turkey.

    abstract:BACKGROUND:There are limited data on the prevalence of the hepatitis B virus (HBV) infection in the agricultural population worldwide. OBJECTIVES:This study aimed to determine the prevalence of HBV infection and associated risk factors in the reproductive-age female farmworker. MATERIALS AND METHODS:This cross-sectio...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.22120

    authors: Yentur Doni N,Simsek Z,Keklik Z,Gurses G,Zeyrek FY

    更新日期:2014-11-23 00:00:00

  • Association of interleukin 18 gene promoter polymorphisms with HBV recurrence after liver transplantation in Han Chinese population.

    abstract:BACKGROUND:There is growing evidence suggesting that interleukin-18 (IL-18) plays a crucial role in viral clearance and disease pathogenesis, and that single nucleotide polymorphisms (SNPs) within the gene may influence its production. OBJECTIVES:To investigate the potential association of two polymorphisms ( 137G/C a...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:

    authors: Wu L,Chen L,Zhou L,Xie H,Wei B,Yin S,Ye Y,Fang W,Zheng S

    更新日期:2011-06-01 00:00:00

  • Fibrosis evaluation by transient elastography in patients with long-term sustained HCV clearance.

    abstract:BACKGROUND:Reversibility of advanced fibrosis after HCV-clearance is an important goal of therapy. OBJECTIVES:Measuring liver stiffness (LS) by transient elastography (TE) might be helpful in this setting. PATIENTS AND METHODS:We evaluated 104 patients with biopsy-proven chronic hepatitis C (CHC) and sustained virolo...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.7176

    authors: Calvaruso V,Di Marco V,Ferraro D,Petta S,Calì A,Grazia Bavetta M,Conte E,Luigi Almasio P

    更新日期:2013-05-11 00:00:00

  • Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV.

    abstract::Patients with chronic hepatitis B infection should be followed up to identify possible changes in disease status, such as HBsAg seronversion. There are little data on the outcome of such cases, and the response rate to HBV vaccine has not been discussed extensively. ...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:

    authors: Alavian SM,Miri SM

    更新日期:2011-02-01 00:00:00

  • Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran.

    abstract:BACKGROUND:In Iran, the number of injecting drug users (IDUs) has increased in recent years. The rates of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections among IDUs are reportedly high. OBJECTIVES:The purpose of this study was to assess factors correlated with HCV and HBV infections among IDUs in Tehran...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/kowsar.1735143X.806

    authors: Amin-Esmaeili M,Rahimi-Movaghar A,Razaghi EM,Baghestani AR,Jafari S

    更新日期:2012-01-01 00:00:00

  • How efficient is acoustic radiation force impulse elastography for the evaluation of liver stiffness?

    abstract:BACKGROUND:In chronic liver diseases, a correct estimation of the severity of liver fibrosis is important for recommendations regarding the treatment. Nowadays, evaluation of fibrosis is done by noninvasive methods such as biochemical scores and transient elastography instead of liver biopsy. The lack of sensitivity to...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:

    authors: Sporea I,Badea R,Sirli R,Lupsor M,Popescu A,Danila M,Focsa M,Deleanu A

    更新日期:2011-07-01 00:00:00

  • The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers.

    abstract:BACKGROUND:Patients with HBeAg-negative chronic hepatitis B (CHB) has a significantly different prognosis than inactive carriers; there is however, no reliable strategy for accurately differentiating these two disease conditions. OBJECTIVES:To determine a strategy for discriminating patients with HBeAg-negative CHB fr...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:

    authors: Kim ES,Seo YS,Keum B,Kim JH,A H,Yim HJ,Kim YS,Jeen YT,Lee HS,Chun HJ,Um SH,Duck Kim C,Ryu HS

    更新日期:2011-05-01 00:00:00

  • Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma.

    abstract:UNLABELLED:CONTEXTS: Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed. EVIDENCE ACQUISITION:At present, radiofrequency ablation (RFA) is accepted as the standa...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.5945

    authors: Himoto T,Kurokohchi K,Watanabe S,Masaki T

    更新日期:2012-10-01 00:00:00

  • Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference?

    abstract:BACKGROUND:Zinc deficiency has been reported frequently in hepatitis C patients in the literature. Furthermore, a decrease in zinc level has been shown in beta thalassemia major as well. Iranians consume a large amount of phytate in their regimens which can bind with zinc and decrease its gastrointestinal absorption. ...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.11138

    authors: Abbasinazari M,Behnava B,Panahi Y,Hajhossein Talasaz A,Salimi S,Keshvari M,Mehrnoush L,Karim Elizee P,Gholami Fesharaki M,Asgharinia M,Alavian SM

    更新日期:2013-08-12 00:00:00

  • Hepatitis B vaccination in chronic kidney disease: review of evidence in non-dialyzed patients.

    abstract:CONTEXT:Hepatitis B vaccination of hemodialysis patients is performed all over the world. There are also recommendations from world health organizations to vaccinate patients with chronic kidney disease (CKD) prior dialysis commencement, but the implementation of a hepatitis B vaccination program is less common and not...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.7359

    authors: Grzegorzewska AE

    更新日期:2012-11-01 00:00:00

  • Egy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: a pilot study.

    abstract:BACKGROUND:Non-invasive methods for assessment of hepatic fibrosis are increasingly needed. Recent studies showed that combined elevation of tumor markers CA 19-9 and CA 125 is predictive of severe hepatic fibrosis or cirrhosis with high specificity. OBJECTIVES:We aimed at developing a new panel of surrogate biomarker...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.10810

    authors: Alboraie MA,Afifi ME,Elghamry FG,Shalaby HA,Elshennawy GE,Abdelaziz AA,Shaheen MU,Abo El-Seoud AR

    更新日期:2013-06-16 00:00:00

  • Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in iran.

    abstract:BACKGROUND:The prevalence of hepatitis C in Iran is 1% and 18% in general population and thalassemia patients respectively. The cost effectiveness analysis of adding Ribavirin to Peginterferon alfa-2a (PEG IFN alfa-2a) as a combination treatment strategy of chronic hepatitis C in thalassemia patients in comparison with...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.10236

    authors: Mehrazmay A,Alavian SM,Moradi-Lakeh M,Mokhtari Payam M,Hashemi-Meshkini A,Behnava B,Miri SM,Karimi Elizee P,Tabatabaee SV,Keshvari M,Bagheri Lankarani K

    更新日期:2013-09-01 00:00:00

  • Construction and preparation of three recombinant adenoviruses expressing truncated NS3 and core genes of hepatitis C virus for vaccine purposes.

    abstract:BACKGROUND:In spite of dozens of clinical trials to establish effective therapeutic and/or preventive vaccine to resolve HCV infection, no real vaccine has been proved to date. Genetic vaccines based on replication-defective adenoviruses have proved to elicit strong and long lasting T-cell responses against a number of...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.6130

    authors: Hosseini SY,Sabahi F,Moazzeni SM,Modarressi MH,Saberi Firoozi M,Ravanshad M

    更新日期:2012-08-01 00:00:00

  • Interferon alpha-2b therapy in chronic hepatitis delta.

    abstract:BACKGROUND:Approximately 5% of hepatitis B virus (HBV) carriers are coinfected with hepatitis D virus (HDV). HBV/HDV coinfection is a major cause of cirrhosis and end stage liver disease in chronic HBsAg carriers. The only approved therapy for chronic hepatitis delta is interferon alpha (IFN α) in either pegylated or c...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.15729

    authors: Keshvari M,Alavian SM,Sharafi H,Karimi G,Gholami Fesharaki M

    更新日期:2014-03-01 00:00:00

  • In Vitro Analysis of CsA-Induced Hepatotoxicity in HepG2 Cell Line: Oxidative Stress and α2 and β1 Integrin Subunits Expression.

    abstract:BACKGROUND:Cyclosporine A (CsA)-induced hepatotoxicity could be due to a reduction in α2β1 integrin expression that may either be from the direct effect of CsA itself or from reactive oxygen species (ROS) overproduction. OBJECTIVES:In this study we aimed to identify the cellular mechanisms underlying CsA-induced hepat...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.11447

    authors: Mostafavi-Pour Z,Khademi F,Zal F,Sardarian AR,Amini F

    更新日期:2013-08-13 00:00:00

  • Health related quality of life in Iranian hemodialysis patients with viral hepatitis: changing epidemiology.

    abstract:BACKGROUND:There are surprisingly a few studies that evaluate the impact of chronic viral hepatitis, which is common in HD (hemodialysis) patients, on HRQOL (health related quality of life). OBJECTIVES:We conducted a study to evaluate the impact of chronic viral hepatitis on HRQOL and to compare their HRQOL with non-i...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.9611

    authors: Rostami Z,Lessan Pezeshki M,Soleimani Najaf Abadi A,Einollahi B

    更新日期:2013-05-30 00:00:00

  • Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China.

    abstract:BACKGROUNDS:Serum hepatitis B surface antigen (HBsAg) levels are associated with fibrosis in patients with chronic hepatitis B (CHB) infection. OBJECTIVES:The aim of our study was to evaluate serum HBsAg level as a biomarker for compensated cirrhosis in hepatitis B e antigen (HBeAg) positive CHB patients. PATIENTS AN...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.29183

    authors: Jia W,Qi X,Ji YY,Xun YH,Wang H,Zhang WH,Yang JH,Wang JY,Zhu HX,Mao RC,Zhang JM

    更新日期:2015-08-30 00:00:00

  • A study of genotypes, mutants and nucleotide sequence of hepatitis B virus in Pakistan: HBV genotypes in pakistan.

    abstract:BACKGROUND:Hepatitis B virus (HBV) genotypes and mutations are gaining importance in determining the clinical course of chronic liver disease. OBJECTIVES:To determine and compare the distribution of HBV genotypes and genomic variations in Pakistan to other parts of the world. PATIENTS AND METHODS:We conducted a prosp...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:

    authors: Mumtaz K,Hamid S,Ahmed S,Moatter T,Mushtaq S,Khan A,Mizokami M,Jafri W

    更新日期:2011-01-01 00:00:00

  • Predictive factors for ultrasonographic grading of nonalcoholic Fatty liver disease.

    abstract:BACKGROUND:There are several studies in the literature investigating factors which can induce non-alcoholic fatty liver disease (NAFLD) in different populations. However, the existing literature lacks powerful studies addressing the factors which may predict the severity of NAFLD. OBJECTIVES:In the current study, we a...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.6860

    authors: Ghamar-Chehreh ME,Khedmat H,Amini M,Taheri S

    更新日期:2012-11-01 00:00:00

  • Intrahepatic Toll-Like Receptor 3 in Chronic HBV Infection Subjects: Asymptomatic Carriers, Active Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma.

    abstract:BACKGROUND:The entire disease spectrum of chronic HBV infection (CHB) includes asymptomatic carriers (AC), active chronic hepatitis (ACH), cirrhosis (Cir), and hepatocellular carcinoma (HCC). Previous study have demonstrated that the costimulation profiles from the livers of patients influenced immune responses and pla...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.34432

    authors: Yin JW,Ping Huang M,Zhong B

    更新日期:2016-05-23 00:00:00

  • G1896A Precore Mutation and Association With HBeAg Status, Genotype and Clinical Status in Patients With Chronic Hepatitis B.

    abstract:BACKGROUND:Precore stop codon (G1896A) mutation is one of the commonest mutations found in patients with chronic hepatitis B. However, over the years, this mutation was not reported much in Malaysia. OBJECTIVES:We therefore investigated the presence of G1896A mutation in Malaysian population and its association with H...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.31490

    authors: Suppiah J,Mohd Zain R,Bahari N,Haji Nawi S,Saat Z

    更新日期:2015-10-28 00:00:00

  • Analysis of T Cell Receptor Vβ Diversity in Peripheral CD4+ and CD8+ T Lymphocytes Obtained From Patients With Chronic Severe Hepatitis B.

    abstract:BACKGROUND:The hepatitis B virus (HBV) antigen-induced cellular immune response plays an important role in HBV clearance. Changes in the diversity of complementarity determining region 3 (CDR3) and T-cell receptor (TCR) sequences are used to monitor the response of T cells to antigens. OBJECTIVES:The aim of the presen...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.15900

    authors: Xiong Y,Tan Y,Song YG

    更新日期:2014-02-25 00:00:00

  • Serological Patterns and Molecular Characterization of Occult Hepatitis B Virus Infection among Blood Donors.

    abstract:BACKGROUND:Hepatitis B infections, characterized by the presence of a viral genome without detectable hepatitis B surface antigen (HBsAg; Occult hepatitis B infection [OBI]), have been reported recently. OBJECTIVES:We performed serological and molecular characterization of OBI among blood donors at Jiangsu province bl...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.40492

    authors: Lin H,Zhao H,Tang X,Hu W,Jiang N,Zhu S,Huang C

    更新日期:2016-10-02 00:00:00

  • The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?

    abstract:INTRODUCTION:Since directly acting antivirals (DAAs) for treatment of hepatitis C virus (HCV) were introduced, conflicting data emerged about the risk of hepatocellular carcinoma (HCC) after interferon (IFN)-free treatments. We present a case of recurrent, extra-hepatic HCC in a liver-transplanted patient soon after su...

    journal_title:Hepatitis monthly

    pub_type:

    doi:10.5812/hepatmon.41933

    authors: Strazzulla A,Iemmolo RMR,Carbone E,Postorino MC,Mazzitelli M,De Santis M,Di Benedetto F,Cristiani CM,Costa C,Pisani V,Torti C

    更新日期:2016-10-30 00:00:00

  • The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C.

    abstract::Approximately 170 million people worldwide are chronically infected by hepatitis C virus (HCV), which can result in progressive hepatic injury and fibrosis, culminating in cirrhosis and end-stage liver disease. The benchmark therapy for untreated HCV patients is a combination of pegylated interferon-alpha (PEG-IFN) an...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:

    authors: Abenavoli L,Mazza M,Almasio PL

    更新日期:2011-04-01 00:00:00

  • A Single Center Study Comparing the Stainable Iron Depositions in 1000 Explanted Cirrhotic Livers of Different Causes.

    abstract:BACKGROUND:There have been very few studies evaluating the close association between excess iron and cirrhosis; however, cirrhosis could be regarded as an iron-loading disorder. OBJECTIVES:In this study, the goal was to show the levels of the iron content in the liver tissue in certain types of cirrhosis. PATIENTS AN...

    journal_title:Hepatitis monthly

    pub_type: 杂志文章

    doi:10.5812/hepatmon.33710

    authors: Geramizadeh B,Ghazanfari Y,Nikeghbalian S,Malekhosseini SA

    更新日期:2015-12-28 00:00:00